Developer docs
API playgroundTry for free, no card

Search company profiles

Mavens

Full company profile

uuid0009pgy

Namestring
Mavens
Legal namestring
Mavens
Websiteurl
mavens.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Mavens, a wholly-owned subsidiary of Komodo Health since 2021, is a certified Salesforce partner that builds cloud-based workflow solutions specifically for the Life Sciences industry. Founded approximately 2009 and operating from offices in New York City, San Francisco, Los Altos, Chicago, and Chennai, the company has accumulated 15+ years of Life Sciences domain expertise and serves 10 of the top 20 global pharmaceutical companies across more than 150 implementations worldwide.

The company's product portfolio centers on the Medical Affairs Suite, comprising three purpose-built Salesforce applications: Scientific Publications Cloud for end-to-end publication planning and management, Medical Information Cloud for inquiry fulfillment with governed agentic AI, and Research & Grants Cloud for managing investigator-initiated trials, medical education grants, expanded access, fellowships, and charitable contributions. Beyond Medical Affairs, Mavens delivers Salesforce Commercial Transformation Services and configures Agentforce Life Sciences for Patient Services, with the latter deployed across 50+ active patient programs supporting 1.7 million+ US target populations. All products leverage Salesforce's Agentforce AI capabilities, Data 360 (formerly Data Cloud), and integrate with Snowflake, Databricks, SAP, DocuSign, Altmetric, Dimensions, and Unpaywall.

Mavens generates revenue through two primary streams: (1) subscription-based SaaS contracts for its Medical Affairs Suite and Agentforce Life Sciences products, typically structured as annual or multi-year enterprise agreements, and (2) professional services revenue from Salesforce Commercial Transformation implementations. The go-to-market is exclusively enterprise direct sales using Request-a-Demo and Contact-Us conversion paths, with no self-serve or SMB tier. Distribution leverages both direct field sales and the certified Salesforce partner ecosystem. The company is heavily concentrated in pharmaceutical enterprise accounts, supported by industry positioning via ISMPP Silver Corporate Sponsorship, MAPS Partner Circle Program Executive membership, and active participation in ISMPP US/EU, MAPS Americas, DIA MASC, and Dreamforce events.

Short descriptiontext

Mavens builds Salesforce-powered workflow solutions for pharmaceutical Medical Affairs and Commercial teams, offering a Medical Affairs Suite (Scientific Publications Cloud, Medical Information Cloud, Research & Grants Cloud) plus Agentforce Life Sciences patient services. The company serves 10 of the top 20 global pharmaceutical companies as a wholly-owned subsidiary of Komodo Health.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical workflow software, medical affairs solutions, life sciences consulting, salesforce implementation services, scientific publications management
Industry1 code
1Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
CodeHLAGAJAMPrimaryYes
NAICS code3 codes
  • Software Publishers5132
  • Software Publishers513210
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming Services7371
Product category
Pharmaceutical Workflow Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Subscriptions - Medical Affairs Suite
TypeSubscription Recurring
Description

Mavens generates revenue through Salesforce-powered SaaS products including Medical Information Cloud, Scientific Publications Cloud, and Research & Grants Cloud. These are subscription-based solutions sold to pharmaceutical companies for Medical Affairs workflows, typically on annual or multi-year contracts.

mavens.com
2Salesforce Commercial Transformation Services
TypeProfessional Services
Description

Professional services revenue from implementing and transforming pharmaceutical commercial operations on Salesforce. Includes strategy, execution, and implementation of Salesforce for Life Sciences, including Agentforce Life Sciences deployments and patient services programs.

mavens.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Mavens® Medical Information Cloud
Description

Salesforce-powered work management solution for medical information teams that brings inquiry management, content, and fulfillment into one place.

mavens.com
+2 more records
Core offering1 text field

Mavens sells Salesforce-powered cloud workflow solutions purpose-built for pharmaceutical Medical Affairs and Commercial teams. The core offering is the Medical Affairs Suite, comprising Scientific Publications Cloud, Medical Information Cloud, and Research & Grants Cloud, augmented by Salesforce Commercial Transformation Services including Agentforce Life Sciences for Patient Services and Data 360 integration. All products leverage Salesforce Agentforce AI capabilities to address regulated Life Sciences workflows.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Scientific Publications Cloud implementations as short as 30 days
+5 more records
Product overview1 text field

Mavens offers a unified Medical Affairs Suite built on Salesforce, comprising three core cloud products: Scientific Publications Cloud for managing publication planning and scientific communications, Medical Information Cloud for handling medical inquiries and content fulfillment with agentic AI, and Research & Grants Cloud for managing funding requests including IITs, grants, and expanded access programs. All products are powered by Salesforce with AI capabilities through Agentforce. The company also provides Salesforce Commercial Transformation Services including Agentforce Life Sciences for Patient Services and Data 360 integration. As a certified Salesforce partner with 15+ years of Life Sciences experience, Mavens serves half of the top 20 pharmaceutical companies.

Product and service6 records
1Mavens® Medical Affairs Suite
CategoryMedical Affairs Workflow Software
Description

Comprehensive Salesforce-powered suite for pharmaceutical Medical Affairs teams encompassing Scientific Publications Cloud, Medical Information Cloud, and Research & Grants Cloud. Trusted by half of the top 20 pharmaceutical companies for modernizing Medical Affairs workflows.

2Mavens® Scientific Publications Cloud
CategoryMedical Affairs Workflow Software
Description

Salesforce-powered work management solution for scientific publications teams that organizes, manages, and advances scientific publications with greater clarity and collaboration. Features configurable timeline views, enterprise scalability, real-time collaboration for authors and reviewers, pre-built Altmetric integration, role-based security, and AI features powered by Agentforce including generative plain language summaries, automatic document quality checks, and an embedded helper agent.

3Mavens® Medical Information Cloud
CategoryMedical Information Management Software
Description

Salesforce-powered work management solution for medical information teams that creates, manages, and fulfills requests for medical information with governed agentic AI. Features omnichannel intake, agentic AI fulfillment with a Tier 1 Agent recommending approved content, hybrid semantic and keyword search (Medical Intelligence), intelligent interaction summary for escalations, centralized content collaboration with traceability, MLR review, and automated adverse event routing.

4Mavens® Research & Grants Cloud
CategoryResearch & Grants Management Software
Description

Salesforce-powered solution for managing all research and grants requests including investigator-initiated trials, medical education grants, research collaborations, expanded access, fellowships, and charitable contributions. Consolidates funding requests into one configurable platform with no-code program builder, configurable workflows, requestor portal with guided intake, SAP financial system integration, DocuSign contract management, and role-based access controls.

5Agentforce Life Sciences for Patient Services
CategoryPatient Services CRM
Description

Salesforce Agentforce-powered patient services solution for pharmaceutical companies supporting specialty, rare, ultra-rare, and cell and gene therapies. Features intelligent enrollment intake that turns faxes and forms into enrollments, automated denial assessment that reviews coverage and appeals, a Patient Review Agent AI assistant for care teams, benefit validation automation, and real-time 360-degree patient and HCP profiles. Backed by Salesforce Shield with SOC 1/2/3 compliance and PHI encryption.

6Salesforce Commercial Transformation Services
CategorySalesforce Implementation Services
Description

Implementation and consulting services for pharmaceutical companies transitioning to Salesforce, including Data 360 migration, Agentforce Life Sciences deployment, and commercial CRM optimization for field sales and patient services. Led by Mavens experts with 15+ years of Life Sciences and certified Salesforce experience.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or Integration
Description

Mavens is a certified Salesforce partner with 15+ years of experience implementing Salesforce for Life Sciences organizations. The company builds its Medical Affairs Suite (Medical Information Cloud, Scientific Publications Cloud, Research & Grants Cloud) and Agentforce Life Sciences patient services solutions on the Salesforce platform. Salesforce is the core technology foundation for all Mavens products.

Strategic tierCoreTypeOthers
Description

Mavens is a wholly-owned subsidiary of Komodo Health. Komodo Health acquired Mavens in 2021. The acquisition has enabled integration of real-world patient data with Mavens' Medical Affairs Suite and extended enterprise impact across the Life Sciences sector. Mavens operates under Komodo Health's mission to reduce the global burden of disease.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Mavens is a Silver Level Corporate Sponsor of ISMPP. The company attends and sponsors ISMPP US and EU annual meetings, hosts roundtables, and actively participates in sessions discussing AI in medical publications. This partnership drives brand awareness and customer acquisition in the medical publications community.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Mavens is a Partner Circle Program Executive member of MAPS. The company attends MAPS Americas and contributes to the medical affairs community through thought leadership, podcast appearances, and sponsorship. Featured in MAPS Elevate podcast on data-driven publications targeting.

Strategic tierMinorTypeOthers
Description

Fresenius Kabi was referenced at Dreamforce 2025 as running its global engagement from a single Salesforce platform across commercial, service, and medical teams. While this is a customer case, it serves as a Salesforce ecosystem reference relevant to Mavens' implementation work.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Accenture's Life Sciences practice delivers large-scale Salesforce and CRM transformation for pharma. Overlaps with Mavens on enterprise implementation but at much larger scale and broader service portfolio.

TypeDirect peer
Description

Axtria is a Life Sciences-focused analytics and CRM consulting firm that delivers commercial and medical technology solutions to pharma. Comparable to Mavens in serving Top 20 pharma customers with Salesforce and adjacent platforms.

TypeDirect peer
Description

Indegene provides technology-led commercial and medical affairs services to biopharma, including content, publications, and AI-enabled engagement. Overlaps with Mavens on pharma Medical Affairs transformation and Salesforce-based delivery.

TypeEmerging player
Description

Sorcero is an AI platform purpose-built for Life Sciences medical affairs and scientific content workflows. Direct thematic overlap with Mavens' Medical Information and Scientific Publications products via AI-driven content automation.

TypeBroad incumbent
Description

IQVIA is a global Life Sciences technology, data, and services incumbent offering its own CRM, R&D, and commercial platforms. While broader in scope, it competes with Mavens on enterprise pharma workflow modernization.

TypeDirect peer
Description

Beghou Consulting is a pharma commercial and medical affairs consultancy that deploys Salesforce-based CRM and analytics solutions for life sciences clients. Closely aligned with Mavens on buyer, technology stack, and use cases.

TypeBroad incumbent
Description

Slalom is a Salesforce Summit partner with a Life Sciences vertical that delivers CRM and analytics transformations. Comparable buyer overlap and Salesforce-native delivery model to Mavens.

TypeBroad incumbent
Description

Deloitte's Salesforce practice serves Top 20 pharma on CRM transformation, including Life Sciences Cloud. Competes with Mavens on enterprise Salesforce deals for large pharmaceutical clients.

TypeDirect peer
Description

Veeva is the incumbent Life Sciences CRM and Medical Affairs platform provider, directly competing with Mavens' Scientific Publications, Medical Information, and Research & Grants products on functionality and customer base. The Veeva–Salesforce split is the central dynamic shaping Mavens' opportunity.

TypeEmerging player
Description

Zifo provides scientific informatics and Salesforce-based solutions to pharma R&D and Medical Affairs. Comparable to Mavens in Life Sciences software and consulting but with a different primary vertical mix.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration11 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mavens

Pharmaceutical Workflow Softwaremavens.com

Mavens builds Salesforce-powered workflow solutions for pharmaceutical Medical Affairs and Commercial teams, offering a Medical Affairs Suite (Scientific Publications Cloud, Medical Information Cloud, Research & Grants Cloud) plus Agentforce Life Sciences patient services. The company serves 10 of the top 20 global pharmaceutical companies as a wholly-owned subsidiary of Komodo Health.

What Mavens does

Mavens, a wholly-owned subsidiary of Komodo Health since 2021, is a certified Salesforce partner that builds cloud-based workflow solutions specifically for the Life Sciences industry. Founded approximately 2009 and operating from offices in New York City, San Francisco, Los Altos, Chicago, and Chennai, the company has accumulated 15+ years of Life Sciences domain expertise and serves 10 of the top 20 global pharmaceutical companies across more than 150 implementations worldwide.

The company's product portfolio centers on the Medical Affairs Suite, comprising three purpose-built Salesforce applications: Scientific Publications Cloud for end-to-end publication planning and management, Medical Information Cloud for inquiry fulfillment with governed agentic AI, and Research & Grants Cloud for managing investigator-initiated trials, medical education grants, expanded access, fellowships, and charitable contributions. Beyond Medical Affairs, Mavens delivers Salesforce Commercial Transformation Services and configures Agentforce Life Sciences for Patient Services, with the latter deployed across 50+ active patient programs supporting 1.7 million+ US target populations. All products leverage Salesforce's Agentforce AI capabilities, Data 360 (formerly Data Cloud), and integrate with Snowflake, Databricks, SAP, DocuSign, Altmetric, Dimensions, and Unpaywall.

Mavens generates revenue through two primary streams: (1) subscription-based SaaS contracts for its Medical Affairs Suite and Agentforce Life Sciences products, typically structured as annual or multi-year enterprise agreements, and (2) professional services revenue from Salesforce Commercial Transformation implementations. The go-to-market is exclusively enterprise direct sales using Request-a-Demo and Contact-Us conversion paths, with no self-serve or SMB tier. Distribution leverages both direct field sales and the certified Salesforce partner ecosystem. The company is heavily concentrated in pharmaceutical enterprise accounts, supported by industry positioning via ISMPP Silver Corporate Sponsorship, MAPS Partner Circle Program Executive membership, and active participation in ISMPP US/EU, MAPS Americas, DIA MASC, and Dreamforce events.

Mavens firmographics

Firmographics
Name
Mavens
Legal name
Mavens
Website
https://mavens.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Short description
Mavens builds Salesforce-powered workflow solutions for pharmaceutical Medical Affairs and Commercial teams, offering a Medical Affairs Suite (Scientific Publications Cloud, Medical Information Cloud, Research & Grants Cloud) plus Agentforce Life Sciences patient services. The company serves 10 of the top 20 global pharmaceutical companies as a wholly-owned subsidiary of Komodo Health.
Ownership category
akta.pro rank

Mavens industry classification

Industry
Product category
Pharmaceutical Workflow Software
NAICS
Software Publishers (5132), Software Publishers (513210), Custom Computer Programming Services (541511)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)
akta.pro primary industry
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

  • Pharmaceutical workflow software
  • Medical affairs solutions
  • Life sciences consulting
  • Salesforce implementation services
  • Scientific publications management

Where Mavens is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Mavens business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Subscriptions - Medical Affairs Suite: Mavens generates revenue through Salesforce-powered SaaS products including Medical Information Cloud, Scientific Publications Cloud, and Research & Grants Cloud. These are subscription-based solutions sold to pharmaceutical companies for Medical Affairs workflows, typically on annual or multi-year contracts.
  2. Salesforce Commercial Transformation Services: Professional services revenue from implementing and transforming pharmaceutical commercial operations on Salesforce. Includes strategy, execution, and implementation of Salesforce for Life Sciences, including Agentforce Life Sciences deployments and patient services programs.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Mavens product offering

Product offering

Core offering

Mavens sells Salesforce-powered cloud workflow solutions purpose-built for pharmaceutical Medical Affairs and Commercial teams. The core offering is the Medical Affairs Suite, comprising Scientific Publications Cloud, Medical Information Cloud, and Research & Grants Cloud, augmented by Salesforce Commercial Transformation Services including Agentforce Life Sciences for Patient Services and Data 360 integration. All products leverage Salesforce Agentforce AI capabilities to address regulated Life Sciences workflows.

Product overview

Mavens offers a unified Medical Affairs Suite built on Salesforce, comprising three core cloud products: Scientific Publications Cloud for managing publication planning and scientific communications, Medical Information Cloud for handling medical inquiries and content fulfillment with agentic AI, and Research & Grants Cloud for managing funding requests including IITs, grants, and expanded access programs. All products are powered by Salesforce with AI capabilities through Agentforce. The company also provides Salesforce Commercial Transformation Services including Agentforce Life Sciences for Patient Services and Data 360 integration. As a certified Salesforce partner with 15+ years of Life Sciences experience, Mavens serves half of the top 20 pharmaceutical companies.

Differentiator

Problem solved

Functional benefit

Brands

  • Mavens® Medical Information Cloud: Salesforce-powered work management solution for medical information teams that brings inquiry management, content, and fulfillment into one place.
  • Mavens® Scientific Publications Cloud
  • Mavens® Research & Grants Cloud

Products and services

  • Mavens® Medical Affairs Suite Comprehensive Salesforce-powered suite for pharmaceutical Medical Affairs teams encompassing Scientific Publications Cloud, Medical Information Cloud, and Research & Grants Cloud. Trusted by half of the top 20 pharmaceutical companies for modernizing Medical Affairs workflows.
  • Mavens® Scientific Publications Cloud Salesforce-powered work management solution for scientific publications teams that organizes, manages, and advances scientific publications with greater clarity and collaboration. Features configurable timeline views, enterprise scalability, real-time collaboration for authors and reviewers, pre-built Altmetric integration, role-based security, and AI features powered by Agentforce including generative plain language summaries, automatic document quality checks, and an embedded helper agent.
  • Mavens® Medical Information Cloud Salesforce-powered work management solution for medical information teams that creates, manages, and fulfills requests for medical information with governed agentic AI. Features omnichannel intake, agentic AI fulfillment with a Tier 1 Agent recommending approved content, hybrid semantic and keyword search (Medical Intelligence), intelligent interaction summary for escalations, centralized content collaboration with traceability, MLR review, and automated adverse event routing.
  • Mavens® Research & Grants Cloud Salesforce-powered solution for managing all research and grants requests including investigator-initiated trials, medical education grants, research collaborations, expanded access, fellowships, and charitable contributions. Consolidates funding requests into one configurable platform with no-code program builder, configurable workflows, requestor portal with guided intake, SAP financial system integration, DocuSign contract management, and role-based access controls.
  • Agentforce Life Sciences for Patient Services Salesforce Agentforce-powered patient services solution for pharmaceutical companies supporting specialty, rare, ultra-rare, and cell and gene therapies. Features intelligent enrollment intake that turns faxes and forms into enrollments, automated denial assessment that reviews coverage and appeals, a Patient Review Agent AI assistant for care teams, benefit validation automation, and real-time 360-degree patient and HCP profiles. Backed by Salesforce Shield with SOC 1/2/3 compliance and PHI encryption.
  • Salesforce Commercial Transformation Services Implementation and consulting services for pharmaceutical companies transitioning to Salesforce, including Data 360 migration, Agentforce Life Sciences deployment, and commercial CRM optimization for field sales and patient services. Led by Mavens experts with 15+ years of Life Sciences and certified Salesforce experience.

Quantifiable outcome

  • Scientific Publications Cloud implementations as short as 30 days
  • +5 more outcomes

Companies that use Mavens

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Mavens technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration11 records

AI capability9 records

Feature5 records

Mavens partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, major and minor.

  • SalesforcecoreTechnology or IntegrationMavens is a certified Salesforce partner with 15+ years of experience implementing Salesforce for Life Sciences organizations. The company builds its Medical Affairs Suite (Medical Information Cloud, Scientific Publications Cloud, Research & Grants Cloud) and Agentforce Life Sciences patient services solutions on the Salesforce platform. Salesforce is the core technology foundation for all Mavens products.
  • Komodo HealthcoreOthersMavens is a wholly-owned subsidiary of Komodo Health. Komodo Health acquired Mavens in 2021. The acquisition has enabled integration of real-world patient data with Mavens' Medical Affairs Suite and extended enterprise impact across the Life Sciences sector. Mavens operates under Komodo Health's mission to reduce the global burden of disease.
  • International Society for Medical Publication Professionals (ISMPP)majorGTM or Marketing PartnerMavens is a Silver Level Corporate Sponsor of ISMPP. The company attends and sponsors ISMPP US and EU annual meetings, hosts roundtables, and actively participates in sessions discussing AI in medical publications. This partnership drives brand awareness and customer acquisition in the medical publications community.
  • Medical Affairs Professional Society (MAPS)majorGTM or Marketing PartnerMavens is a Partner Circle Program Executive member of MAPS. The company attends MAPS Americas and contributes to the medical affairs community through thought leadership, podcast appearances, and sponsorship. Featured in MAPS Elevate podcast on data-driven publications targeting.
  • Fresenius KabiminorOthersFresenius Kabi was referenced at Dreamforce 2025 as running its global engagement from a single Salesforce platform across commercial, service, and medical teams. While this is a customer case, it serves as a Salesforce ecosystem reference relevant to Mavens' implementation work.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Mavens competitors and assessment

Company assessment

Broad incumbents

  • Accenture Life Sciences: Accenture's Life Sciences practice delivers large-scale Salesforce and CRM transformation for pharma. Overlaps with Mavens on enterprise implementation but at much larger scale and broader service portfolio.
  • IQVIA: IQVIA is a global Life Sciences technology, data, and services incumbent offering its own CRM, R&D, and commercial platforms. While broader in scope, it competes with Mavens on enterprise pharma workflow modernization.
  • Slalom: Slalom is a Salesforce Summit partner with a Life Sciences vertical that delivers CRM and analytics transformations. Comparable buyer overlap and Salesforce-native delivery model to Mavens.
  • Deloitte Digital (Salesforce practice): Deloitte's Salesforce practice serves Top 20 pharma on CRM transformation, including Life Sciences Cloud. Competes with Mavens on enterprise Salesforce deals for large pharmaceutical clients.

Direct peers

  • Axtria: Axtria is a Life Sciences-focused analytics and CRM consulting firm that delivers commercial and medical technology solutions to pharma. Comparable to Mavens in serving Top 20 pharma customers with Salesforce and adjacent platforms.
  • Indegene: Indegene provides technology-led commercial and medical affairs services to biopharma, including content, publications, and AI-enabled engagement. Overlaps with Mavens on pharma Medical Affairs transformation and Salesforce-based delivery.
  • Beghou Consulting: Beghou Consulting is a pharma commercial and medical affairs consultancy that deploys Salesforce-based CRM and analytics solutions for life sciences clients. Closely aligned with Mavens on buyer, technology stack, and use cases.
  • Veeva Systems: Veeva is the incumbent Life Sciences CRM and Medical Affairs platform provider, directly competing with Mavens' Scientific Publications, Medical Information, and Research & Grants products on functionality and customer base. The Veeva–Salesforce split is the central dynamic shaping Mavens' opportunity.

Emerging players

  • Sorcero: Sorcero is an AI platform purpose-built for Life Sciences medical affairs and scientific content workflows. Direct thematic overlap with Mavens' Medical Information and Scientific Publications products via AI-driven content automation.
  • Zifo Technologies: Zifo provides scientific informatics and Salesforce-based solutions to pharma R&D and Medical Affairs. Comparable to Mavens in Life Sciences software and consulting but with a different primary vertical mix.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Mavens social profiles

Digital presence

Mavens compliance and trust

Trust signal

Compliance4 records

Mavens financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mavens leadership team

Management profile

Number of profiles

Profiles5 records

Mavens funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mavens M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mavens

What does Mavens do?

Mavens sells Salesforce-powered cloud workflow solutions purpose-built for pharmaceutical Medical Affairs and Commercial teams. The core offering is the Medical Affairs Suite, comprising Scientific Publications Cloud, Medical Information Cloud, and Research & Grants Cloud, augmented by Salesforce Commercial Transformation Services including Agentforce Life Sciences for Patient Services and Data 360 integration. All products leverage Salesforce Agentforce AI capabilities to address regulated Life Sciences workflows.

Is Mavens a public or private company?

Mavens is a private company. It is classified as corporate owned and is currently operating.

When was Mavens founded?

Mavens was founded in 2009. It employs 51 to 100 people.

Where is Mavens based?

Mavens is headquartered in Chicago, United States, in the North America region.

How does Mavens make money?

Two revenue lines are on record. SaaS Subscriptions - Medical Affairs Suite is the primary driver. The others are salesforce Commercial Transformation Services.

Who are Mavens's main competitors?

Broad incumbents on record are Accenture Life Sciences, IQVIA, Slalom and Deloitte Digital (Salesforce practice). Direct peers are Axtria, Indegene, Beghou Consulting and Veeva Systems. Emerging players are Sorcero and Zifo Technologies.

Does Mavens have an API?

No public API is recorded for Mavens.

What industry is Mavens in?

Mavens's product category is Pharmaceutical Workflow Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Healthcare IT TodayKomodo Health Acquires Mavens on Heels of Komodo’s $44 Million Series D FundingKomodo Health announced the acquisition of Mavens, a cloud-based technology solutions provider for life sciences companies. The deal combines Komodo's Healthcare Map™—which tracks over 320 million de-identified patient journeys—with Mavens' enterprise applications to create a unified data-driven platform for healthcare and life sciences. The acquisition comes shortly after Komodo raised $44 million in Series D funding led by ICONIQ Growth, and will accelerate Komodo's global expansion as Mavens currently operates in the US, UK, and India.citybizKomodo Health Acquires MavensKomodo Health announced its acquisition of Mavens, a cloud-based technology solutions provider for the life sciences industry, combining Komodo's Healthcare Map™—which tracks over 320 million de-identified patient journeys—with Mavens' enterprise applications to create what they claim is the most advanced data-driven enterprise platform for healthcare. The deal, terms undisclosed, will expand Komodo's global presence as Mavens currently operates in the U.S., U.K., and India. Komodo Health previously raised $44 million in Series D funding led by ICONIQ Growth, and the acquisition is expected to reduce the burden of disease by helping life sciences companies more efficiently deliver therapies to patients.BioSpaceKomodo Health Acquires Mavens, Creating the First Data-Driven Enterprise Platform for Life SciencesKomodo Health has acquired Mavens, a cloud-based technology solutions provider for the life sciences industry, in a deal that combines Komodo's Healthcare Map™ (tracking over 320 million de-identified patient journeys) with Mavens' enterprise applications to create an advanced data-driven platform for healthcare and life sciences companies. The acquisition is expected to accelerate Komodo's global expansion, as Mavens currently operates in the U.S., U.K., and India. Komodo Health recently raised $44 million in Series D funding led by ICONIQ Growth to support this acquisition and further expand its platform capabilities.Healthcare IT NewsKomodo Health acquires Mavens to create healthcare enterprise platformKomodo Health acquired Mavens, a provider of cloud-based tools for biotech and specialty pharma, to create a healthcare enterprise platform. The deal terms were undisclosed, but Komodo's Series D raised $44 million. The combined platform aims to connect patients with therapies and shift toward a patient-centric data model.HIT ConsultantKomodo Health Acquires Cloud-Based Life Sciences Platform Mavens- M&AKomodo Health acquired Mavens, a cloud-based life sciences platform, to expand its software capabilities. The deal, terms undisclosed, will integrate Mavens' software with Komodo's Healthcare Map, which uses data from over 320 million de-identified individuals. The acquisition supports Komodo's global expansion across the U.S., U.K., and India.FierceBiotechKomodo Health to acquire Mavens after undisclosed $44M VC roundHealthcare data startup Komodo Health plans to acquire Mavens, a developer of cloud-based software for biotech and pharma companies, after a prior VC round of $44 million led by ICONIQ Capital. The deal aims to enhance Komodo’s Healthcare Map and support its global expansion into the U.S., U.K., and India.GlobeNewswireVineti launches new Alliance Network -- and announces a collaboration with Mavens -- to deliver integrated solutions for cell and gene therapiesVineti announced a new Vineti Alliance Network to help advanced therapy manufacturers source supply chain vendors, and partnered with Mavens to integrate their Cell & Gene Navigator with Vineti's platform. The collaboration aims to provide a 360-degree view of the patient journey for cell and gene therapies.PR NewswireMavens is Latest Member of Industry Standards Group, Align BiopharmaMavens announced its membership in Align Biopharma on July 13, 2017, becoming one of 15 new member companies to join the industry technology standards group that same day. Align Biopharma is an industry standards group comprising 23 leading biopharma companies and technology and service providers, dedicated to creating open technology standards that facilitate digital connections between healthcare professionals and life sciences companies. The organization stated that the growing number of new drugs and digital content channels has increased the need for standardized technology solutions in the sector.